Support independent, student-run journalism.

Your support helps give staff members from all backgrounds the opportunity to conduct meaningful reporting on important issues at Stanford. All contributions are tax-deductible.

Stanford researchers criticize Theranos-like biomedical ‘unicorns’ for lack of published research

Today, a new generation of innovative biomedical startups continue to win billion-dollar valuations and massive infusions of venture capital as they promise to revolutionize medicine and disrupt massive healthcare markets. According to a new January paper authored by three Stanford researchers, many of these companies also publish little to no peer-reviewed research.